Delayed wound healing is a Type 2 diabetes mellitus (DM) complication caused by hyperglycemia, systemic inflammation, and decreased blood microcirculation. Skeletal muscles are also affected by hyperglycemia, resulting in reduced blood flow and glucose uptake. Low Magnitude High Frequency Vibration (LMHFV) has been proven to be beneficial to muscle contractility and blood microcirculation. We hypothesized that LMHFV could accelerate the wound healing of n5-streptozotocin (n5-STZ)-
Exercise is a well-established method to control the blood glucose level and is the main strategy to treat type 2 DM patients 1 . However, DM patients with complications may have difficulties in regular daily exercise. Low magnitude high frequency vibration (LMHFV) has been proven as an alternative to conventional exercise that can stimulate metabolic responses 9 . In clinical and preclinical studies, LMHFV has been reported to have benefits on muscle contractibility functions 10 , muscle structures and strength 11 . It has also been proven to be effective in inducing tissue regeneration, and promoting blood flow 12 . Ten minutes of vibration treatment can significantly increase the blood flow of healthy adults between 18-43 years old 13 . Non-DM patients have also shown reduced blood glucose levels after vibration treatments 14 . These are the essential criteria in accelerating a DM wound healing process.
In this study, we hypothesized that LMHFV could accelerate the foot wound healing process of n5-STZ-induced DM rats by enhancing skeletal muscle activities to increase glucose uptake, reduce blood glucose, and enhance blood microcirculation to increase cell proliferation and angiogenesis. The objective was to investigate the effects of LMHFV on the DM foot wound healing process using neonatal n5-STZ-induced DM rats by comparing with no-treatment DM rats (DM) and non-DM rats at Days 1, 4, 8 and 13 post wounding.
Results
Rat Physical Health. DM rats increased their food and water uptakes beginning at week 5 after birth. The average blood glucose level of DM rats in both groups before open-wound induction was about 483.47 ± 91.46 mg/ dL, while those of non-DM rats was about 106.6 ± 1.8 mg/dL. Wound Morphology. Wounds created (Day 0) were consistent in size and shape with minimal to no bleeding in all groups. The wound size of all groups were increased at Day 1, as the edges of the wounds were stretched further apart due to edema and swelling on the whole foot Fig. 1A . Swelling at the foot wound continued in DM rats at Day 13, but subsided in DM_V rats at Day 8. At Day 13, the wound size of the DM_V rats (2.90 ± 1.23 mm 2 ) was significantly smaller (p = 0.018) than the DM rats (4.16 ± 1.30 mm 2 ). The wound area of the Ctrl_V rats (Day 8, 6.04 ± 1.88 mm 2 ; Day 13, 2.64 ± 0.26 mm 2 ) were significantly smaller than Ctrl rats (Day 8, 7.91 ± 1.80 mm 2 ; Day 13, 4.09 ± 1.75 mm 2 ) (p = 0.036 and 0.022, respectively). Swelling at the foot wound of Ctrl rats subsided as early as Day 4. At Day 8, the wound area of the DM rats (9.29 ± 0.88 mm 2 ) was significantly larger (p = 0.048) than that in the Ctrl rats (7.91 ± 1.80 mm 2 ) Figs 1B and 8. The wound size of all groups stretched far apart due to edema and swelling expanded to the whole foot at Day 1 post wounding. Swelling at the foot wound of DM rats continued at Day 13, but the DM_V rats subsided at Day 8. (B) At Day 13, the wound size area of the DM_V rats was significantly smaller than those of the DM rats. The wound size of the Ctrl_V rats were significantly smaller than those in Ctrl rats at Days 8 and 13 post wounding. At Day 8, the wound size area of the DM rats was significantly larger than that in the Ctrl rats. **Significant difference. Histology. At Day 1, a new epithelium was observed on the surface of the wound for both DM groups. By Day 4, the epithelial layer of DM_V rats was more complete than DM rats. A crust or scab was observed on the wound surface of the DM_V rats. By Day 8, more granulation tissue was observed in DM_V rats than those of DM rats Fig. 4 .
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Expression of PECAM-1. PECAM-1 was performed to evaluate the presence of endothelial cells in the wound. PECAM-1 of DM_V rats (21.13 ± 7.69%) was significantly higher (p = 0.042) than those of DM rats (10.15 ± 8.56%) at Day 4. By Days 8 and 13, PECAM-1 of DM_V rats (Day 8, 13.37 ± 4.53%; Day 13, 7.28 ± 3.86%) was significantly lower than those of DM rats (Day 8, 19.63 ± 4.84%; Day 13, 18.80 ± 11.19%) (p = 0.056, and 0.053, respectively) Fig. 5A . PECAM-1 of Ctrl_V rats (Day 1, 12.19 ± 5.19%; Day 13, 25.90 ± 5.79%) were significantly higher than those of Ctrl rats (Day 1, 6.25 ± 2.89%; Day 13, 17.81 ± 3.44%) (p = 0.035 and 0.018, respectively), but Ctrl_V rats (14.34 ± 1.57%) was significantly lower (p = 0.000) than those of Ctrl rats (24.17 ± 4.09%) at Day 8. Comparing between vibration groups, PECAM-1 of DM_V rats (21.13 ± 7.69%) was significantly higher (p = 0.03) than those of Ctrl_V rats (7.08 ± 1.88%) at Day 4, but significantly lower (p < 0.05) by Day 13 Figs 5B and 8. Expression of VEGF. VEGF was performed to evaluate angiogenesis 15 . VEGF of DM_V rats (Day 8, 21.80 ± 3.70%; Day 13, 19.97 ± 6.40) were significantly higher than those of DM rats (Day 8, 11.38 ± 3.53%; Day 13, 10.45 ± 2.04%) (p = 0.001 and 0.013, respectively) Fig. 6A . VEGF of Ctrl_V rats (Day 4, 11.78 ± 3.99%; Day 8, 23.06 ± 7.3%; Day 13, 27.73 ± 8.91%) were significantly higher than those of Ctrl rats (Day 4, 7.07 ± 3.18%; Day 8, 9.21 ± 1.96%; Day 13, 14.09 ± 10.29%) (p = 0.048, 0.005, and 0.034, respectively). Comparing between vibration groups, VEGF of Ctrl_V rats (15.44 ± 1.5%) was significantly higher than those of DM_V rats (8.53 ± 4.32%) at Day 1 (p = 0.038) Figs 6B and 8.
Expression of PCNA.
PCNA was performed to evaluate cell proliferations. PCNA of DM_V rats (Day 8, 19.22 ± 4.63%; Day 13, 8.97 ± 2.80%) were significantly higher than those of DM rats (Day 8, 8.06 ± 3.93%; Day 13, 4.24 ± 3.50%) (p = 0.001 and 0.028, respectively) Fig. 6C . PCNA on Ctrl_V rats (19.11 ± 4.63%) was significantly higher (p = 0.038) than those of Ctrl rats (11.81 ± 4.44%) at Day 8 Fig. 8 . 85 ng/ml) was significantly lower (p = 0.006) than those of Ctrl rats (37.46 ± 4.88 ng/ml) at Day 13. The CRP levels of DM rats (Day 4, 52.92 ± 7.62 ng/mL; Day 8, 53.03 ± 2.66 ng/ mL) were significantly higher than those of Ctrl rats (Day 4, 39.60 ± 5.83ng/mL; Day 8, 38.28 ± 2.01 ng/mL) (p = 0.007 and 0.000, respectively). Comparing between vibration groups, the CRP levels of DM_V rats (Day 4, 51.80 ± 9.75 ng/mL; Day 8, 50.05 ± 7.45 ng/mL; Day 13, 50.81 ± 8.62 ng/mL) were significantly higher than those of Ctrl_V rats (Day 4, 33.91 ± 6.70 ng/mL; Day 8, 32.87 ± 4.71 ng/mL; Day 13, 27.17 ± 2.85 ng/mL) (p = 0.007, 0.004, and 0.000, respectively) Figs 7B and 8.
C-Reactive Protein (CRP). CRP was used as a marker to compare systemic inflammation between groups
Discussions
This study investigates the effects of LMHFV on the foot wound healing process using n5-STZ-induced DM rats. Our results revealed that LMHFV accelerated the foot wound healing process in both DM (DM_V) and non-DM rats (Ctrl_V). The foot wounds of the DM_V rats healed significantly faster by LMHFV compared to DM rats at Day 13, and Ctrl_V rats healed even faster with significant differences at Days 8 and 13 than those of Ctrl rats. LMHFV also significantly enhanced GLUT4 expression by stimulating muscle activities of DM_V rats to increase glucose uptake and to reduce the blood glucose level. Blood microcirculation was also improved in both DM (DM_V) and non-DM (Ctrl_V) rats to enhance cell proliferation, angiogenesis, and local inflammatory response LMHFV had enhanced the muscle activities of DM_V rats by significantly increasing their GLUT4 expression for glucose uptake and reducing their blood glucose level at Days 8 and 13. According to Stewart et al., type IIa fibers contract at the rates of 20-70 Hz 16 and our previous studies also showed these fibers were more sensitive to LMHFV than other muscle fiber types in the gastrocnemius to improve muscle functions 11 . Since approximately 22% of gastrocnemius is composed of type IIa fibers 17 , LMHFV had enhanced muscle activities by triggering type IIa fibers to increase GLUT4 expression for glucose uptake. Hussey et al. observed that a single bout of acute exercise on a cycle ergometer for an hour increased GLUT4 in skeletal muscles of type 2 DM patients by increasing AMPK and p38 MPK phosphorylation 18 . Since Hargreaves et al. had demonstrated that glucose uptake was enhanced by facilitated diffusion after increasing blood flow in contracting skeletal muscle 19 , our flux data further supported that LMHFV enhanced glucose uptake after increasing blood flow systemically. Del Pozo-cruz et al. also showed vibration could significantly reduce HbA1c and fasting blood glucose in DM patients after a 12-week vibration treatment 20 , indicating that enhanced muscle activities can indirectly reduce the blood glucose level. Studies have shown that exercise could enhance glucose uptake in type 2 DM patients with different signaling pathways 1 , but the exact mechanism on which LMHFV triggers type IIa fibers to release GLUT4 expression and increase glucose uptake needs further study to clarify.
LMHFV had significantly enhanced blood microcirculation to increase PECAM-1 during the inflammatory phase, and PCNA and VEGF during the proliferative and angiogenesis phases to accelerate wound healing. Weinheimer-Haus et al. reported that low intensity vibration (LIV) at 45 Hz, 0.4 g for 30 min/day for 5 days/week could accelerate wound healing in mice by increasing blood flow to enhance angiogenesis and granulation tissue formation/re-epithelialization at day 7 post wounding 4 . In our previous published paper, we have used both 3-D high-frequency power Doppler and micro-computed tomography (microCT) microangiography to demonstrate that LMHFV could increase blood flow and angiogenesis in both normal and osteoporotic fractures at the femora 21 . Our data had indicated that LMHFV has significantly enhanced the skin blood microcirculation (Day 4 and 13) and VEGF (Day 8) of DM_V rats more than those of DM rats. In the inflammatory phase, PECAM-1 recruits leukocytes at inflammatory sites and across the endothelial layer 22 . Since PECAM-1 is an indicator for the presence of endothelial cells in the wound, LMHFV might have significantly enhanced PECAM-1 through shear stress on endothelial cells to modulate inflammatory signaling pathways 23 . PECAM-1 was also significantly reduced after leukocytes emigrated 24 . This supports our data that PECAM-1 was significantly enhanced at Day 4 and reduced at Days 8 and 13 in DM_V rats. Furthermore, PCNA of DM_V rats was also enhanced at Days 8 and 13. Since PCNA is an indicator of epidermal proliferation and granulation tissue formation, LMHFV might have also induced mechanical stress in DM_V rats to create an inflammatory response to enhance cellular proliferation for tissue repair 25 . Our histology images further showed that more granulation tissues were formed in the wounds of the DM_V rats than those of the DM rats since Day 8. Granulation formation is related to blood microcirculation since regions of granulation have a higher blood flow than those without granulation 26 . Thus, LMHFV might have promoted granulation tissue formation by enhancing blood microcirculation and angiogenesis in wound to accelerate wound healing. The blood microcirculation of Ctrl_V rats was significantly lower than those of Ctrl rats at Days 8 and 13. This might be because the wound size of Ctrl_V rats was also significantly reduced at the same time requiring lower blood flow to complete the wound healing process. Rendell et al. also reported that the blood flow in the paw wounds of non-DM rats was significantly reduced at Day 7 post wounding 27 . This indicates that the microvascular structure of the wound of Ctrl_V rats might be nearly completed to regulate blood microcirculation normally. Comparing between DM and non-DM groups, all expressions of Ctrl_V rats were significantly different at an earlier wound healing process from those of DM_V rats. The PECAM-1 of Ctrl_V rats was significantly enhanced at Day 1 but reduced at Day 8 than DM_V rats. The VEGF of Ctrl_V rats were significantly higher than those of DM_V rats at Day 1. Ctrl_V rats had significantly higher PCNA than Ctrl rats at Day 8. This evidence further explained why the wound area of Ctrl_V rats healed earlier than DM_V rats.
LMHFV had little effect in reducing the CRP level in DM_V rats because it was positively associated with hyperglycemia independently 28 . Although the blood glucose level of DM_V rats was significantly reduced at Days 8 and Day 13, it remained high (>300 mg/dl) after a two-week vibration treatment. Thus, the CRP level may not be reduced until hyperglycemia is controlled. Increased platelet reactivity might be another explanation, since elevated CRP level in blood was observed in DM patients after exercise 29 . Comparing between DM and non-DM rats, the CRP level of Ctrl_V rats was significantly lower than those of DM_V rats at Days 4, 8, 13 post wounding. The CRP level of Ctrl_V rats was also significantly lower than those in Ctrl rats at Day 13. These observations indicated that inflammation was significantly reduced in non-DM rats since Day 4 post wounding, and LMHFV further reduced the CRP level in Ctrl_V rats.
Figure 6.
Comparison of PCNA and VEGF immunohistochemistry between Ctrl, Ctrl_V, DM, and DM_V groups (n = 6/timpoint). (A) VEGF of DM_V rats were significantly higher than those of DM rats at Days 8 and 13 post wounding. VEGF of Ctrl_V rats were significantly higher than those of Ctrl rats at Days 4, 8, and 13 post wounding. (B) Comparing between vibration groups, VEGF of Ctrl_V rats was significantly higher than those of DM_V rats at Day 1. (C) PCNA of DM_V rats were significantly higher than those of DM rats at Days 8 and 13. PCNA on Ctrl_V rats was significantly higher than those of Ctrl rats at Day 8. **Significant difference. Note: Arrows indicate PCNA and VEGF expressions.
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The differences of tissue architectures and immune responses 30 in wound healing between humans and rats are limitations to this study. The open wound model used is not equivalent to a human's chronic non-healing wound 31 , but its characteristics match with the clinical observations of a DM foot ulcer to study the wound healing process of a DM wound. In western blot analysis, we only used one loading control to compare with GLUT4 expression. Although Vigelso et al. only recommended not using beta-actin as loading control if muscle samples are obtained from elderly or with a large age difference 32 and multiple literatures also used beta-actin as the loading control 33, 34 , we could use another loading control such as GAPDH to double check its reliability. Furthermore, we only measured the wound area of each rat based on how its wound closed up at different time points but did not measure the wound depth of each rat because we lack the technique to measure them precisely in this study.
In conclusion, LMHFV accelerated an open foot wound healing process of n5-STZ-induced type 2 DM rats by enhancing muscle activities to increase glucose uptake and reduce the blood glucose level, and improving blood microcirculation to increase cell proliferation and angiogenesis. Non-DM rats with vibration treatments healed the fastest compared to other groups with earlier enhancement of wound healing factors including blood flow and cell proliferation. Due to hyperglycemia, the wounds of DM_V rats healed slower than Ctrl_V rats, but much faster than DM rats. Reduced blood glucose level of DM_V rats at Days 8 and 13 might explain the enhancement of VEGF, PCNA, and GLUT4 expressions at the same time. These indicators showed evidences that the wound healing process of DM_V rats was significantly accelerated by LMHFV. Therefore, LMHFV is recommended as an alternative non-invasive therapeutic device to accelerate the skin wound healing process in DM patients. 35 . In both DM groups, 5-day-old Wistar rats were intraperitoneally injected with streptozotocin (STZ, Sigma-Aldrich, 70 mg/kg) that was freshly dissolved in 0.1 M citrate buffer (pH 4.5). Rats were supplied by and kept in the Laboratory Animal Service Center of the Chinese University of Hong Kong (CUHK) and resided in a room with a 12-h light-dark cycle. Based on our established protocol, the DM status of STZ-induced rats was confirmed at 10-week old with a Contour Plus glucometer (Bayer Healthcare, Germany) 36 . Rats with a blood glucose level ≥300 mg/dL were randomized to either DM or DM_V group.
Methods
Animal Model and Study Design.
The 
Foot Wound Creation.
Induction of an open foot wound was based on an excisional model 35 to produce more scar tissue for analysis 37 . In past DM foot ulcer/wound studies, the wound location was usually created on the back of the rats/mice [38] [39] [40] [41] . Few papers induced a wound on plantar skin of the paw 42 or at the dorsum of the foot 43 , but none of these models used type 2 DM rats/mice. Since 90% of DM patients worldwide are type 2 DM 6 and approximately 5-7% of them will eventually have foot ulcer 44 Nine weeks after STZ injection, a glucometer (Contour Plus, Bayer Healthcare, Germany) was used to determine the blood glucose level of each rat. Adult rats with a blood glucose level of ≥300 mg/dl were used. On the day of open wound induction (Day 0), each rat was anesthetized with 75 mg/kg ketamine and 10 mg/kg xylazine. The skin on the right footpad of the hindlimb was shaved and a 2 mm × 5 mm rectangular full thickness wound was created. The wound size used in this experiment was based on standard wound models 30 .
Low Magnitude High Frequency Vibration (LMHFV) Treatment. LMHFV treatment was started at
Day 1 post wounding, which the DM_V and Ctrl_V rats stood on a LMHFV platform (35 Hz, 0.3 g) for 20 min/ day, 5days/week until endpoint 45 . DM and Ctrl rats also stood on the LMHFV platform with the same regime with the power off. Treatments were given in the morning from Monday to Friday for consecutively 5 days per week. The break was set at the weekends. The transmission of mechanical signal to hindlimbs have been validated and reported in our previous study 12 . The rats were placed on the platform by housing individually in a bottomless compartmented cages with their hindlimbs touching well to the platform, where the partitions were in black to minimize the surrounding disturbance.
Wound Size Measurement. The wound area was measured with a photo imaging software (SPOT 3.5.5
Window) 36 . Before wound area measurement, the wound edges of the wound were defined by comparing the color difference in the wound area and those of nearby non-wounded skin area of the same rat. The color of the wounded skin and non-wounded skin were distinguished using the magnetic lasso tool of Photoshop CS6 software before using the photo imaging software (SPOT 3.5.5 Window) to calculate the wound area. Rat wounds and a metric ruler with standardized 1 cm × 1 cm squares were photographed simultaneously. Digital photographs of the injury site were taken using a Canon SX50HS digital camera. The wound size was calculated and measured using the software based on the standardized squares.
Blood Glucose Level. Blood glucose was collected from the tail and analyzed with a Contour Plus glucometer (Bayer Healthcare, Germany) 35 . The blood glucose level of each rat was monitored at each time point until scarification.
Glucose Transporter 4 (GLUT4) by Western Blot. Total protein of glucose transporter 4 (GLUT4) was extracted from gastrocnemius 46 . Each sample was homogenized and centrifuged at 11,000 g for 20 minutes. The supernatant was determined with the Pierce BCA Protein Assay Kit (Thermo Scientific, Massachusetts, USA). 40 μg proteins/sample was denatured and separated in 10% SDS-PAGE. Primary antibody GLUT4 (1F8) Mouse mAb (Cell Signaling Technology, Massachusetts, USA) was applied at 1:1000 dilution and incubated at 4 °C overnight. After incubation, the membranes were incubated with anti-mouse IgG, HRP-linked antibody (1:5000 diluted in TBST) at 37 °C for 60 min. The protein bands were visualized with Clarity Western ECL Blotting Substrates (Bio-Rad, California, USA), following the manufacturer's guidelines and quantified using ImageJ software (NIH, Maryland, USA). β-Actin was used as reference protein. 
